Fig 1: Working model of DIAPH3 function in aNPC.(A) During mitosis, diaphanous three (DIAPH3) maintains the dynamics of cytoskeleton. Polarity proteins nuclear mitotic apparatus (NUMA) and G-protein signaling modulator 2 (GPSM2) assemble underneath cortical F-actin and recruit the dynein/dynactin motor protein complex. Dynein and dynactin interact with SPAG5/KNSTRN/CLASP1 located at the microtubule plus-end and attach astral microtubule (MT) to cell cortex, thus providing the pulling force for chromosome bipolar segregation (Okumura et al., 2018; Dunsch et al., 2011; Kern et al., 2016). (B) The position of polarity proteins NUMA/GPSM2 directs the orientation of the mitotic spindle and determines the type of division (proliferative versus neurogenic) of apical neural progenitor cells (aNPCs). (C, D) Absence of DIAPH3 destabilizes actin and MT and disrupts the expression of SPAG5, KNSTRN, GPSM2, PAR3, and NUMB, therefore weakening astral MT-cell cortex and spindle MT-kinetochore interactions. This causes spindle abnormalities, chromosome mis-alignment, and mis-segregation, and alters the fate decision of aNPCs.
Fig 2: Characterization of the microtubule-associated protein fraction of WT and Tubb6 KO osteoclasts. (A) Schematic representation of the osteoclast fractionation strategy in microtubule-stabilizing Tub/MT buffer to obtain soluble proteins (S1), a fraction enriched in microtubule-binding protein (S2) and an insoluble fraction containing microtubules (P). (B) Representative immunoblot analysis of selected protein distribution between the different fractions: Vinculin, CLASP1, acetylated K40 α-tubulin, β-tubulin, actin, and Histone H3. (C) Volcano plot of Label Free Quantitation (LFQ) results from four independent mass spectrometry experiments, showing proteins that are significantly more abundant in S2 from KO (top left) and WT (top right) osteoclast, with vertical lines indicating twofold change cut off and horizontal line p = 0.01 cut off, with x axis in log2(LFQ WT/LFQ KO) and y axis in –log10(p-value). (D) Representative immunoblot analysis of ARHGAP10, TUBB6 and GAPDH expressions in WT or Tubb6 KO RAW264.7 cells (Pre-OC) and in the osteoclasts (OC) derived from these cells.
Fig 3: The KA1 domain influences CLASP1 interaction and plasma membrane localization.A) On the left, the sequence alignment of the C-terminus of MARK1-4, which is part of the ~100 amino acid KA1 domain. On the right, the sequence alignment of the C-terminus of MARK1-3. The truncation point for the MARK2 2–745 mutant is indicated (MARK2 F745). B) Western blot analysis of the co-IP of FLAG-tagged MARK1 as well as MARK2 wild type (WT) and respective mutants with endogenous CLASP1 and 14-3-3 proteins. EGFP is coexpressed via an IRES from all expression plasmids. C) Western blot analysis of the corresponding input, resolving AMPK motif and ζXKXGSXXNΨ motif phosphorylation inside endogenous CRTCs and tau. D) Western blot analysis of the co-IP of FLAG-tagged CLASP1 with HA-tagged SIK2, MARK1-4, and the MARK2 2–745 truncation mutant. For the HA-tagged MARK2 construct transcript variant 3 was used (TV3: MARK2 1–724; UniProt Q7KZI7-4), while the MARK2 2–745 mutant was generated in transcript variant 4 background (UniProt Q7KZI7-1). The P-MARK AL antibody detects the activation loop phosphorylation of overexpressed MARK1-4 as well as an endogenous HEK 293T cell signal at ~ 85 kDa (see blue arrow). E) Representative immunofluorescence image of HEK 293T cells transfected with consecutive C-terminal truncation mutants of FLAG-tagged MARK2. Cells were stained for the FLAG epitope and imaged for EGFP, which is coexpressed via an IRES from the expression plasmids. (scale bar indicates 20 μm).
Fig 4: Comparison of MARK2 and SIK2 reveals differences in ζXKXGSXXNΨ motif phosphorylation and interactions with CLASP proteins.A) Confirmed and putative phosphorylation sites of MARKs and SIKs [9–13, 45]: Common AMPK family substrate motifs in cAMP-regulated transcriptional co-activators (CRTCs: CRTC1-3) and class IIA Histone deacetylases (HDACs: HDAC4,5,7,9) as well as ζXKXGSXXNΨ motifs in tau (numberings are according to Homo sapiens CRTC/HDAC proteins, Tau-441, and isoform 1 of MAP2/4). # indicates motifs that were previously shown to be phosphorylated by both MARKs and SIKs. B) To scale schematic depiction of H. sapiens MAP/microtubule affinity-regulating kinase 2 (MARK2 1–788) and salt-inducible kinase 2 (SIK2 1–926). MARK2 and SIK2 share homology inside their N-terminal kinase domain (KD) and are both activated by LKB1, but encode distinct C-termini. C) Representative immunofluorescence image of HEK 293T cells transfected with FLAG-tagged MARK2 and SIK2, which were expressed from the constitutive Ubiquitin C promoter (UbC). These plasmids coexpress EGFP via an internal ribosome entry site (IRES). Cells were stained for the FLAG epitope and either imaged for EGFP (MARK2) or counterstained with DAPI (SIK2). (scale bar indicates 20 μm). D) Tables show the recovery of N-terminally FLAG-tagged MARK2 (F-MARK2; hMARK2 TV4) and SIK2 (F-SIK2 AA, with AA = S358A S587A) subjected to mass spectrometry (MS) analysis following the co-IP (SPCs = spectral counts). Recovery of endogenous 14-3-3 ε (YWHAE) and CLIP-associating proteins (CLASP1/2) are indicated. Samples were either treated with the adenylyl cyclase activator Forskolin (Fsk; 10 μM for 1h) or the DNA-damaging agent Doxorubicin (DOX, 10 μM for 4h) prior to cell lysis and IP-MS protocol. In case of SIK2 AA one sample was not only subjected to trypsin but also to pepsin proteolytic digest. E) Western blot analysis of the co-IP of FLAG-tagged GFP, MARK2, and SIK2 with endogenous CLASP1 and 14-3-3 proteins. Prior to the co-IP, cells were treated for 1 h with either DMSO or 10 μM Fsk for 1h. F) Western blot analysis of the corresponding input, resolving MARK activation loop phosphorylation (P-MARK AL; blue arrow indicates endogenous HEK 293T cell signal at ~ 85 kDa) as well as phosphorylation of AMPK and ζXKXGSXXNΨ motifs inside CRTCs and tau. EGFP is coexpressed via an IRES from all expression plasmids.
Fig 5: The MARK family displays distinct CLASP1 interactions and subcellular localizations.A) To scale schematic depiction of H. sapiens MARK family (MARK1-4). At the N-terminus all MARKs contain an unstructured region, followed by the kinase domain (KD), the ubiquitin-associated domain (UBA), a variable regulatory domain, and at the C-terminus the kinase associated 1 (KA1) domain. Phosphorylation at a conserved threonine inside the activation loop by either LKB1 or TAOK1 activates MARKs and phosphorylation within the regulatory domain controls 14-3-3 binding and subcellular localization (among other kinases by aPKC). B) Western blot analysis of the co-IP of FLAG-tagged MARK1-4 with endogenous CLASP1 and 14-3-3 proteins. Additionally, two truncation constructs of MARK2 were assayed: The N-terminal kinase domain of MARK2 (MARK2 1–307) and the C-terminus of MARK2, which starts at the UBA domain (MARK2 307–788). C) Western blot analysis of the corresponding input, resolving AMPK and ζXKXGSXXNΨ motif phosphorylation inside endogenous CRTCs and tau. D) Representative immunofluorescence image of HEK 293T cells transfected with FLAG-tagged MARK1, the inactive MARK2 T208A S212A activation loop mutant, MARK3, and both MARK4 isoforms (MARK4S and MARK4L) that differ at their C-termini [42]. Cells were stained for the FLAG epitope and imaged for EGFP, which is coexpressed via an IRES from all expression plasmids. (scale bar indicates 20 μm).
Supplier Page from Abcam for Anti-CLASP1 antibody [EPR3409]